Targeting hypoxia-inducible factors with 32-134D safely and effectively treats diabetic eye disease in mice.
J Clin Invest
; 133(13)2023 07 03.
Article
in En
| MEDLINE
| ID: mdl-37227777
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Retinal Neovascularization
/
Diabetes Mellitus, Experimental
/
Diabetic Retinopathy
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
J Clin Invest
Year:
2023
Document type:
Article
Affiliation country:
United States
Country of publication:
United States